Literature DB >> 29316578

Acute hepatitis as a prequel to very severe aplastic anemia.

Christina Weiler-Normann1, Johannes Hartl1, Sören Weidemann2, Ute-Marie von Pein3, Walter Fiedler4, Christoph Schramm1, Florian Brinkert5, Nicolaus Kröger3, Maximilian Christopeit3.   

Abstract

Severe aplastic anemia is a rare and potentially life-threatening disease of the bone marrow often requiring allogeneic hematopoietic stem cell transplantation. Pathogenesis of the disease can vary and often remains enigmatic. Occasionally, severe aplastic anemia is associated with prior severe acute hepatitis. Differential diagnosis of acute non-viral hepatitis challenges the physician as pathogenesis remains unclear.We here present a case of a young patient presenting with acute hepatitis followed by severe aplastic anemia successfully treated with allogeneic hematopoietic stem cell transplantation. Due to immunosuppressive treatment with azathioprine for acute hepatitis of putative autoimmune pathogenesis and coincident infection with parvovirus B19, diagnosis of the sequential disease of acute hepatitis followed by severe aplastic anemia was complicated. We discuss the caveats and present a review of the literature. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29316578     DOI: 10.1055/s-0043-121737

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  2 in total

1.  Successful Treatment of a 19-Month-Old Boy with Hepatitis Associated Aplastic Anemia by Infusion of Umbilical Cord-Derived Mesenchymal Stromal Cells: A Case Report.

Authors:  Liu Fang; Lim Meikuang; Guo Ye; Chen Xiaojuan; Yang Wenyu; Ruan Min; Chang Lixian; Wang Weiqiang; Han Zhibo; Han Zhongchao; Zhu Xiaofan
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

2.  Cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with hepatitis E virus: The bone marrow as a possible new viral target.

Authors:  Fernanda de Oliveira Bottino; Noemi Rovaris Gardinali; Sarah Beatriz Salamene Salvador; Andreza Soriano Figueiredo; Lynn Barwick Cysne; Juliane Siqueira Francisco; Jaqueline Mendes de Oliveira; Marcelo Pelajo Machado; Marcelo Alves Pinto
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.